Pillstats
Rx only · Injection, Solution, Concentrate · Intravenous

Cyclophosphamide

Cyclophosphamide

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US3 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL01AA01
RxCUI (US)3002
US makers1 labelers
Packages3
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/an/a163248642025 Q12025 Q22025 Q32025 Q42026 Q1
28
Rx · 2026 Q1
292
Units dispensed
3
Quarters · since 2025 Q3

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Sandoz Incunknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Sep 5, 2025
    RECALLRecall (Class II): Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Sterile, 5mL Multiple Dose Vial, Manufactu…

    cGMP deviations: Temperature excursion during transportation. — Recalling firm: Sandoz Inc — Nationwide in the USA